Pratz, Keith W.Jonas, Brian A.Pullarkat, VinodRecher, ChristianSchuh, Andre C.Thirman, Michael J.Garcia, Jacqueline S.DiNardo, Courtney D.Vorobyev, VladimirFracchiolla, Nicola S.Yeh, Su-PengJang, Jun HoOzcan, MuhitYamamoto, KazuhitoIllés, ÁrpádZhou, YingDail, MoniqueChyla, BrendaPotluri, JalajaDöhner, Hartmut2022-02-222022-02-222022Journal Of Clinical Oncology. -40 : 8 (2022), p. 855-865. -J. Clin. Oncol. - 0732-183X. - 1527-77550732-183X1527-7755http://hdl.handle.net/2437/328773Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidinefolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM100442OrvostudományokKlinikai orvostudományokhttps://ascopubs.org/doi/10.1200/JCO.21.01546http://dx.doi.org/10.1200/JCO.21.015462022-03-2300076592230000885125966990